INCE the germ cell theory espoused by Friedman and Moore 10 was applied to intracranial pineal or suprasellar-hypothalamic tumors, the pathology and treatment of intracranial germ cell tumors have attracted much attention. However, many questions have remained unanswered because of the low incidence of these tumors (approximately 3.1% of all primary brain tumors in Japan
without treatment of marked intracranial hypertension soon after their admission underwent autopsy. Surgical specimens and autopsy materials were examined with hematoxylin and eosin staining, silver impregnation, and immunostaining for human chorionic gonadotropin (HCG), ␣-fetoprotein (AFP), and placental alkaline phosphatase. Using the World Health Organization classification, 24 the tumors were classified into five basic types or into mixed tumor types (mixed germ cell tumor) if they consisted of two or more components. These tumor types are germinoma, teratoma, yolk sac tumor or endodermal sinus tumor, choriocarcinoma, and embryonal carcinoma. Teratomas were divided into three subtypes according to the degree of differentiation of the tumor cells: mature and immature teratomas and teratoma with malignant transformation. We defined tumors as "pure" when only one histological component was observed in routinely prepared histopathological specimens. The serum titers of HCG and AFP were examined in 92 patients. The radiological method of diagnosis in 66 patients who were treated before the advent of CT scanning consisted of pneumoencephalography or pneumoventriculography; the other 87 patients were examined by CT scanning with or without MR imaging.
Tumor Location
Seventy-eight tumors (51%) were located in the pineal region, 46 (30.1%) in the neurohypophysis, five (3.3%) in the basal ganglia, four (2.6%) in the cerebellopontine angle, three (2%) in the lateral ventricle, three (2%) in the cerebellum, and one (0.7%) in the corpus callosum; 13 tumors (8.5%) developed at multiple sites. After the introduction of CT technology, we found that 13 (14.9%) of 87 patients had multiple tumors. These tumors were mainly located in the pineal region in five patients, in the neurohypophysis in seven, and diffusely along the ventricular wall in one patient.
Survival Analysis
Excluded from the analysis of survival data were six patients who died before any treatment could be started, seven patients who had exhibited persistent intracranial hypertension with cerebral herniation preoperatively and who died after surgery, two patients who were lost to follow up, and four patients who have just finished their initial treatment. Thus, we were able to evaluate a total of 134 patients who were followed for more than 9 months (range 9 months-27 years, median 8.1 years). The duration of survival was calculated from the date of surgery to the date of death using the Kaplan-Meier method. Equality was tested with the generalized Wilcoxon test or the log-rank test.
Results

Clinical Symptoms and Signs
Of 79 patients with tumors in the pineal region, 75 (94.9%) manifested symptoms and signs of intracranial hypertension. Parinaud's sign and Argyll Robertson pupil were observed in 72.4% and 42.1% of these patients, respectively; 24.1% complained of diplopia. Auditory impairment 26, 34, 40 was a rare symptom, noted in three patients.
Of 50 patients with neurohypophyseal tumors, 43 (86%) presented with diabetes insipidus. Visual disturbance, including narrowing of the visual field and decreased visual acuity, was observed in 85.4% of the patients. Of 14 females older than 12 years, 13 (92.9%) manifested primary or secondary amenorrhea. Growth retardation was noted in 10 (30.3%) of 33 patients younger than 15 years.
Of five patients with tumors in the basal ganglia, three had increased intracranial hypertension, two demonstrated hemiparesis, and one had epilepsy. All four patients with tumors in the cerebellopontine angle presented with symptoms attributable to this region; all three patients with tumors in the cerebellum showed marked intracranial hypertension. Three patients with tumors in the lateral ventricle presented with intracranial hypertension (three patients), epilepsy (one patient), and hemiparesis (one patient); one patient with a tumor in the corpus callosum had diplopia. Patients with tumors in both the pineal and neurohypophyseal regions manifested signs characteristic of tumors at both sites.
The clinical signs and symptoms of the different histological subtypes were not specific except for intratumoral hemorrhage, which was found in all three patients with choriocarcinoma, in one patient who had germinoma with syncytiotrophoblastic giant cells (STGCs), and in one patient with a mixed tumor composed primarily of embryonal carcinoma.
Six patients less than 10 years of age (five boys and one girl 23 ) presented with precocious puberty. Their tumors were located in the pineal region (four patients), in the neurohypophysis (one patient), and in both regions (one patient). The histological diagnoses in these cases were choriocarcinoma (one patient), immature teratoma (two patients), mature teratoma (two patients), and mixed tumor (one patient). Of four patients whose serum HCG titers were examined, elevated levels were found in two (one patient with choriocarcinoma and one patient with immature teratoma).
Histological Diagnosis
The histological diagnoses (Tables 1 and 2) were germinoma in 55 patients (35.9%), germinoma with STGCs in eight (5.2%), teratoma in 30 (19.6%), embryonal carcinoma in five (3.3%), choriocarcinoma in three (2%), yolk sac tumor in three (2%), and mixed tumor in 49 patients (32%). Of the four cases of teratoma with malignant transformation, the malignant elements were epidermal carcinoma in three cases and sarcoma in one case. In the mixed tumors, the component most frequently presented was germinoma (37 cases, 75.5%) followed by teratomatous components (36 cases, 73.5%). Immature teratomatous elements were observed in 27 mixed teratomas. None of the mixed tumors was a combination of germinoma and choriocarcinoma (Table 2) .
There were 13 patients with multiple tumors: eight were histologically diagnosed as germinomas, two as germinomas with STGCs, and three as mixed tumors. Of the eight germinomas, the main tumors were located in the pineal region in two cases and in the neurohypophysis in six cases. Of a total of 55 germinomas, 25 arose from the neurohypophysis and the same number from the pineal region.
As shown in Table 1 , only two of 78 pineal tumors (2.6%) were found in females. None of the female patients had tumors in the basal ganglia; however, slightly more females than males (25 vs. 21) had tumors in the neurohypophysis. All but one of the 19 mature teratomas were found in males; the preponderant site (17 of 19) was the pineal region. In our series, no female patient had histologically identified choriocarcinoma or yolk sac tumor.
There were no statistically significant differences among the various histological subtypes with regard to patient age, tumor location (pineal region, 14.6 Ϯ 6, mean Ϯ standard deviation; neurohypophyseal region, 14.5 Ϯ 5.4), or gender (males 16.6 Ϯ 8.5; females 14 Ϯ 6.4) ( Table 1) .
Radiological Findings
Computerized tomography scans of good quality were available for detailed analyses in 73 patients; 22 of these patients were also examined by MR imaging. On CT scans, germinomas (24 cases) were visualized as high-or slightly high-density areas with homogeneous enhancement. Mature teratomas (five patients) were characterized by a clear margin, mixed density, and frequent large cysts and areas of calcification. Immature or malignant teratomas (nine patients) had a pattern similar to that of mature teratomas, except for the obscure tumor margin, perifocal edema, fewer cystic components, and smaller areas of calcification. Pure malignant tumors were generally visualized as an irregularly shaped mass with heterogeneous enhancement and perifocal edema. Mixed germ cell tumors (21 patients) had a characteristic heterogeneous appearance, and MR images were useful for detecting teratomatous, particularly fatty, components. Calcification was observed in 33 cases (45.2%): 14 (41.2%) in 34 pure and mixed germinomas; 16 (53.3%) in 30 pure and mixed teratomas; and three (60%) in five yolk sac tumors. We have reported a detailed analysis of neuroradiological images elsewhere. 11 
Serum Titers of AFP and HCG
The serum titers of AFP and/or HCG were elevated in 36 of 92 patients ( Table 3 ). None of the 29 patients with germinomas and none of the seven patients with mature teratomas had elevated titers. All three patients with choriocarcinomas and one patient with a mixed tumor consisting mainly of choriocarcinoma had a highly elevated serum HCG (2120-32,000 mIU/ml and 6000 mIU/ml, respectively), whereas patients with tumors other than choriocarcinomas presented with serum HCG titers less than 770 mIU/ml: 40 to 690 mIU/ml in all seven patients with germinomas with STGCs, 30 to 590 mIU/ml in five patients with immature and malignant teratomas, and 61 to 770 mIU/ml in four patients with mixed tumors. Highly elevated AFP titers were recorded in all three patients with yolk sac tumors (2700-9500 ng/ml) and in three patients with mixed tumors consisting mainly of yolk sac tumors (3380-6700 ng/ml); less elevated titers were observed in three patients with immature teratomas (7.5-500 ng/ml), two with embryonal carcinomas (183-700 ng/ml), and 11 with mixed tumors consisting of a small part of immature teratoma, embryonal carcinoma, or yolk sac tumor (7.3-1810 ng/ml).
Surgical Procedures
Surgery was performed in 147 patients. The occipital transtentorial, frontal transcallosal, or infratentorial supracerebellar approach was generally used in patients with pineal tumors and the pterional or subfrontal approach in patients with neurohypophyseal tumors. Extensive removal (gross-total or subtotal removal) was achieved in 40.8% of surgically treated tumors. Partial removal or biopsy was generally performed for neurohypophyseal tumors to protect visual acuity and neurohypophyseal function. Partial removal or biopsy was also used for pineal tumors that demonstrated a highly malignant histology with high vascularity and invasion into the surrounding brain (Table 4) .
Seven patients died after surgery; preoperatively, all seven exhibited marked intracranial hypertension with cerebral herniation. Major complications, such as mental retardation due to pre-or postoperative prolonged intracranial hypertension or hemiparesis, were encountered in nine patients; seven of these patients had pineal tumors. The overall mortality and morbidity rates were 4.8% and 6.1%, respectively; in patients treated after 1980 they were slightly better at 2.6% and 2.6%, respectively (Table 5).
Treatment Outcomes
Treatment outcomes were evaluated in 134 patients (50 with germinomas, seven with germinomas with STGCs, 16 with mature and seven with immature teratomas, four with teratomas with malignant transformation, five with choriocarcinomas, three with yolk sac tumors, three with embryonal carcinomas, and 39 with mixed tumors). In this discussion, we apply the term "malignant teratoma" to immature teratomas that contained immature embryonic structures of malignant character and to teratomas with malignant transformation. The term "pure malignant germ cell tumors" is applied to pure-type choriocarcinomas, embryonal carcinomas, and yolk sac tumors.
Before 1981, radiation therapy with a median tumor dose of 50 Gy was used postoperatively in all patients except those in whom mature teratomas were totally removed. Radiation was generally delivered to the local field in patients with germinomas and teratomas and to the whole brain followed by a boost to the tumor site in patients with other malignant tumors. After 1981, chemotherapy was delivered as an important adjuvant treatment in patients with nongerminomatous malignant tumors (Table 6 ). Our chemotherapy regimens are a cisplatin-vinblastine-bleomycin combination (PVB), a cisplatin-etoposide combination (PE), and a carboplatinetoposide combination (CE, a modified PE). These combination treatments originally were used in patients with testicular nonseminomatous germ-cell tumors. 3, 9 The PVB and PE therapies were outlined in the phase II study of the Japanese Intracranial Germ Cell Tumor Study Group. 28, 44 Of 50 patients with germinoma, 43 received postoperative radiation therapy alone; the other seven underwent postoperative chemotherapy and radiation therapy. In the former group, radiation therapy was begun within 2 weeks after surgery and consisted of a total dose of 40 to 62 Gy (median 50 Gy) in 20 to 30 fractions. In 37 patients it was delivered to a generous local field 30 encompassing the tumor site and the third and lateral ventricles as well as the sellar and pineal regions; in two patients it was delivered only to the tumor area (limited local field). Seven patients received irradiation to the whole brain followed by boost irradiation to the tumor area, three received irradiation to the whole brain, and one received irradiation to the whole neuroaxis. The most recent seven patients with neurohy- pophyseal tumors also received chemotherapy; PE or CE therapy was delivered prior to radiation therapy to reduce radiation damage to the anterior pituitary by decreasing the radiation dose (30 Gy). A total of 45 patients are still alive. The 5-, 10-, 15-, and 20-year survival rates in patients with germinomas were 95.4%, 92.7%, 87.9%, and 80.6%, respectively ( Table 7 ). All patients treated after 1974 are alive. Of the five deceased patients, one died of postoperative hypothalamic failure, three of unknown causes in other hospitals, and one of general malaise without tumor recurrence 17 years after treatment. Three patients who were treated by generous or limited local radiation had recurrent or disseminated tumors outside the irradiated field; these patients were successfully treated again by additional radiation therapy to the tumor site. A good quality of life involving school or employment was reported in 19 (83%) of 23 patients still living after more than 10 years. Of the seven patients who had germinoma with STGCs, four were treated by postoperative radiation therapy alone and three patients underwent chemotherapy and radiation therapy. The median dose of radiation delivered was 50 Gy (range 41-60 Gy). One patient in the former group and two in the latter presented with local tumor recurrence; this occurred within 2.5 years of treatment in two patients and within 4 years of treatment in one patient. Two of these patients were successfully treated again, and the 5-and 10-year survival rates of all seven patients were both 83.3%.
The 10-year survival rate in 16 patients with mature teratoma was 92.9%; 14 of these patients underwent subtotal or total tumor removal alone, and two were treated by subtotal removal or biopsy of the tumor followed by radiation therapy. The 10-year survival rate in 11 patients with malignant teratoma was 70.7%. Extensive surgery with radiation therapy and chemotherapy succeeded in local control (four [80%] of five patients), whereas total removal alone or partial removal with radiation therapy resulted in a high rate of recurrence (five [83%] of six patients). There was no statistically significant difference in survival rates between patients with mature teratoma and those with malignant teratoma (p = 0.5258). 
* Histological abbreviations are defined in Table 4 . CE All patients with pure malignant germ cell tumors (five embryonal carcinomas, three yolk sac tumors, and three choriocarcinomas) showed a poor 3-year survival rate of 27.3%; the 1-year survival rate was 0% for choriocarcinoma, 33.3% for yolk sac tumor, and 80% for embryonal carcinoma patients. Only one patient with embryonal carcinoma is alive without tumor recurrence 8 years after surgery.
The 5-and 10-year survival rates in 39 patients with mixed tumors were 57.1% and 40.1%, respectively. When these mixed tumors were divided into three subgroups according to the tumor components they contained (mixed germinoma and teratoma, mixed tumors mainly consisting of predominant germinoma or teratoma combined with a small portion of pure malignant tumors, or mixed tumors mainly consisting of pure malignant elements), the 3-and 5-year survival rates were 94.1% and 84.7% for the first group, 70% and 52.5% for the second, and 9.3% and 9.3% for the third group, respectively. The differences were statistically significant (p = 0.0098) ( Table 7 , Fig. 1 ).
For pure malignant tumors and mixed tumors in the pineal region, extensive surgical removal precipitated a statistically better survival rate compared to partial removal or biopsy (Fig. 2) . However, this analysis is biased in that the number of patients undergoing extensive removal is much larger in the moderately malignant groups (the mixed germinoma and teratoma and the mixed germinoma or teratoma with a small portion of malignant tumors) than in the highly malignant groups (mixed tumors consisting mainly of malignant elements and pure types of choriocarcinoma, embryonal carcinoma, and yolk sac tumor) ( Table 4) .
The most recent 26 consecutively admitted patients with malignant tumors (seven with pure malignant tumors, 13 with mixed tumors, and six with malignant teratomas) received chemotherapy with cisplatin or carboplatin combinations before or after radiation therapy, whereas conventional radiation therapy alone with a median tumor dose of 50 Gy was delivered to the previous 31 patients (Table 6 ). Overall, the combination of chemotherapy and radiation was not significantly more effective than radiation treatment alone (Fig. 3) . A detailed analysis showed that chemotherapy had no significant effect in patients with moderately malignant tumors (mixed germinoma and teratoma or mixed germinoma or teratoma with a small portion of malignant tumors) and in patients with highly malignant tumors (mixed tumors consisting mainly of malignant elements or pure types of choriocarcinoma, embryonal carcinoma, and yolk sac tumors), even though patients in the former group tended to show a lower recurrence rate of 11.1% (one of nine patients) after receiving combined chemotherapy and radiation compared with patients who received radiation treatment alone (seven [41.2%] of 17 patients). Details will be reported elsewhere.
Of the 61 nongerminomatous malignant germ-cell tumors treated, 34 (55.7%) recurred or metastasized (Table  8 ). The rate of tumor recurrence increased with histological malignancy. The site of recurrence was the primary
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Intracranial germ cell tumors 451 Table 4 . -= data could not be calculated because the follow-up period was too short or because there were too few survivors. site alone (20 cases), the primary site and a remote site (five cases), the brain outside the primary site (three cases), and the spinal cord alone (four cases); two patients had systemic metastasis alone. Overall, 25 patients (73.5%) had tumor recurrence at the primary site with or without remote recurrence. There were no statistically significant differences in the median time to recurrence between the two moderately malignant tumors, or between the two highly malignant tumors; however, the median time to recurrence in the moderately malignant groups (208 weeks) was longer than that in the highly malignant groups (39.3 weeks) (p Ͻ 0.001). The recurrence rate was higher in patients who had undergone partial removal compared to those with extensive surgery (p Ͻ 0.01). Between the group treated by surgery and radiation therapy and the group treated by surgery, radiation therapy, and chemotherapy, there was no statistically significant difference in the recurrence rate (58.1% vs. 50%) or in the median time to recurrence (105.7 weeks vs. 178.6 weeks).
Discussion
A statistical analysis report published by the Committee of Brain Tumor Registry of Japan 5 indicates that the incidence of germ cell tumors is 3.1% of all primary brain tumors and that they comprise 71.1% of all pineal tumors and 3.7% of parasellar tumors. Although this incidence in Japan is the highest one in the world, it is still very small. Our study group, which consists of 153 histologically verified cases, is the largest single group reported to date.
Analysis of the clinical data collected here revealed that: 1) pineal germ cell tumors were rare in females (two of 78 cases), although females had a slightly higher incidence of neurohypophyseal tumors (25 of 46 cases) than males (21 of 46 cases) ( Table 1) ; 2) tumors in the basal ganglia were observed only in males; 3) germinomas were located as often in the neurohypophysis (25 cases) as in the pineal region (25 cases); 4) none of the mature teratomas was located in the neurohypophysis; 5) of the 153 patients, seven (4.6%) had tumors in the posterior fossa; and 6) the clinical symptoms and signs in our patients coincided with those reported by others. 4, 7 Jennings, et al., 21 who analyzed 398 reported cases of germ cell tumor, reported a small number of female patients (6%) with pineal tumors; Inoue and colleagues 16 recorded only one female of nine patients with tumors in the basal ganglia. This was not the case for tumors in the neurohypophyseal region (57% in the series by Jennings, et al., 21 72% in Ho and Liu's series, 14 75% in the series of Hoffman and coworkers, 15 and 54% in our series). Males also predominated with respect to choriocarcinoma and mature teratomas, although their predominance was not as strong in yolk sac tumors. Itoyama, et al., 17 reported that four of six patients with AFP-producing pineal tumors were females.
Jennings, et al., 21 and Bjornsson and associates 2 reported a higher incidence of suprasellar (neurohypophyseal) germinomas than pineal germinomas (58% vs. 37% and 49% vs. 38%, respectively). On the other hand, Hoffman and coworkers 15 and Ho and Liu 14 made the opposite observation; in their series more germinomas were located in the pineal than in the neurohypophyseal area (62% vs. 32% and 47% vs. 30%, respectively). Overall, it appears that the incidence of germinoma in the neurohypophyseal region tends to be similar to, or slightly higher than, the incidence of these tumors in the pineal region.
Our search of the literature detected only two cases of pure mature teratoma in the parasellar region. 18, 25 The posterior fossa is a rare tumor site. 8, 38, 42 Surveys of CT scans and tumor markers (AFP and HCG) were not particularly helpful in obtaining a differential diagnosis of histological subtypes (Table 3) . 11 These marker proteins are sometimes secreted by immature teratomas or embryonal carcinomas. The titers of HCG and AFP reflected the number of cells secreting these proteins; this is useful for differentiating tumors with predominant choriocarcinoma 43 or yolk sac tumor from other kinds of marker-secreting tumors. Table 4 . Extensive = subtotal or gross-total removal; partial = partial removal or biopsy.
The treatment outcomes differed among histological subtypes (Table 7) . Tumors composed of cells resembling the cells in the earlier stages of histogenesis are generally more malignant than those resembling the cells in the later stage of histogenesis. In germ cell tumors, each subtype may represent the neoplastic correlate of an embryonic stage of development: the trophoblast (choriocarcinoma), which appears as early as the stage of the blastocyst; the yolk sac endoderm (yolk sac tumor or endodermal sinus tumor); the pluripotential stem cell of the embryo proper (embryonal carcinoma); the embryonic differentiated cell (teratoma); and the primordial germ cell (seminoma or germinoma). 36 In fact, our treatment results showed that the shortest survival rates were found in patients with choriocarcinoma followed by those with yolk sac tumor, embryonal carcinoma, and mixed tumors consisting mainly of these components. Patients with germinoma and teratoma had the longest survival rates. The report by Jennings, et al., 21 supports our hypothesis. According to the germ cell theory, 10 choriocarcinoma is the most differentiated and germinoma the least differentiated tumor. We have proposed a hypothesis for the pathogenesis of intracranial germ cell tumors from the perspective of embryonic development. 36 In patients with germinoma, radiation therapy after surgery produced an excellent 15-year survival rate of 87.9% (Table 7) . Tumor recurrence or dissemination occurred in three patients (6%) and was suspected in three other patients who died of unknown causes. According to the literature, approximately 10% of patients with germinoma experienced recurrence or dissemination. 6, 37 Some of the recurrent tumors developed in the irradiated field; others were noted outside the field. These results suggest that pure germinomas seldom disseminate or metastasize and that irradiation to the generous local field, encompassing the tumor site and the third and lateral ventricles as well as the sellar and pineal regions, is adequate. 30 The local irradiation contributed to good quality of life (with respect to school and employment) in 83% (19 of 23 cases) of long-surviving patients. Jenkin, et al., 20 reported schoolrelated difficulties in children with germinomas who were treated by whole-brain irradiation. Dattoli and Newall 6 and Shibamoto, et al., 39 also recommended local irradiation for germinomas. However, long-standing anterior pituitary dysfunction was reported in patients with neurohypophyseal germinoma. 30 We have just begun a clinical trial in which we deliver chemotherapy prior to radiation therapy with a reduced dose (24 Gy) to protect anterior pituitary function.
Germinomas with STGCs are not as easily controlled by radiation therapy as pure germinomas: three of seven patients developed recurrent tumors. Aggressive chemotherapy should be combined with radiation therapy in the initial treatment.
Eleven patients with immature teratomas and teratomas with malignant transformation showed a better 5-year survival rate (70.7%) than was predicted based on their histological malignancy. Further analysis of the treatment indicated that extensive removal of the tumor and postoperative radiation therapy and chemotherapy were effective.
The 5-and 10-year survival rates in 39 patients with mixed tumors were statistically different (Table 7) , suggesting that histological confirmation of the elements comprising the mixed tumors is important for determining the most effective treatment.
Radiation therapy has produced less satisfactory results in nongerminomatous malignant tumors than in germinomas. 21, 31 The Japanese Intracranial Germ Cell Tumors Study Group reported a median survival time of 18 months and a rate of dissemination through the cerebrospinal fluid or hematogeneous metastasis of 45% in 33 malignant tumors treated with irradiation, even though radiation therapy produced an excellent short-term response in 90% of cases with a definite reduction in tumor volume or a decreased serum titer of AFP of HCG. 28 Combination chemotherapy with PVB was effective for testicular and extragonadal malignant germ cell tumors. 9 A 2-year survival rate of 67.7% was recorded for 30 patients with intracranial malignant germ cell tumors treated by PVB therapy; this was slightly better than the 46.5% for patients treated by radiation therapy alone. 28 Combination chemotherapy was effective in some patients with intracranial malignant germ cell tumors; 22, 29, 32 however, the effect of chemotherapy has not yet been evaluated in a large study group.
In the treatment of nongerminomatous malignant tumors, the combination of chemotherapy and radiation therapy in our most recent 26 consecutive patients was not significantly more effective than radiation therapy alone in the previous 31 patients (Fig. 3) , even though some patients survived for more than 5 years. 29 An analysis of the treatment failure pointed to a high incidence of local failure (73.5%), suggesting the need for more intensive induction treatment with aggressive chemotherapy and radiation at the primary site. The lower recurrence rate in patients with moderately malignant germ cell tumors (mixed germinoma and teratoma or mixed germinoma or
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Intracranial germ cell tumors 453   FIG. 3 . Graph showing the probability of survival according to the treatment modality. Chemotherapy with or without radiation therapy was not significantly more effective than radiation therapy alone in patients with malignant teratomas, mixed tumors, and pure malignant tumors. Combination therapy was not significantly effective in patients with moderately malignant MGT or MXB and in patients with highly malignant MXM or PM. CMT = combination of chemotherapy plus radiation therapy and chemotherapy alone. RT = radiation therapy alone (31 patients). Histological abbreviations are defined in Table 4 and Fig. 1. teratoma with a small portion of malignant tumors) suggests the efficacy of our combination therapy.
These treatment analyses led us to classify intracranial germ cell tumors into three therapeutic groups with good prognosis, intermediate prognosis, and poor prognosis ( Table 9) . These groups require different treatment modalities. The first step should be histological verification by surgery with possibly an extensive mass reduction. Although the role of surgery in survival remains unevaluated, the recurrence rate was low in patients who had undergone extensive surgery (Table 8) . Advances in microsurgical techniques and radioimaging have made surgery for pineal tumors much safer, with a mortality rate of less than 5%. 27, 40 In patients with nongerminomatous malignant tumors, locally administered radiation therapy does not control tumor progression and a course of systemic chemotherapy with cisplatin or carboplatin followed by radiation therapy is necessary. For the group with intermediate prognosis (Table 9) , PE or CE therapy can control tumor growth; for the most malignant group with poor prognosis, more aggressive chemotherapy should be administered. 
